154 related articles for article (PubMed ID: 33668712)
1. Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates.
Samiee-Zafarghandy S; van Donge T; Allegaert K; van den Anker J
Children (Basel); 2021 Feb; 8(3):. PubMed ID: 33668712
[TBL] [Abstract][Full Text] [Related]
2. Methadone dosing strategies in preterm neonates can be simplified.
van Donge T; Samiee-Zafarghandy S; Pfister M; Koch G; Kalani M; Bordbar A; van den Anker J
Br J Clin Pharmacol; 2019 Jun; 85(6):1348-1356. PubMed ID: 30805946
[TBL] [Abstract][Full Text] [Related]
3. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.
Gaalema DE; Heil SH; Badger GJ; Metayer JS; Johnston AM
Drug Alcohol Depend; 2013 Nov; 133(1):266-9. PubMed ID: 23845658
[TBL] [Abstract][Full Text] [Related]
4. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
5. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
6. The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
Lemon LS; Naimi A; Caritis SN; Platt RW; Venkataramanan R; Bodnar LM
Paediatr Perinat Epidemiol; 2018 Mar; 32(2):213-222. PubMed ID: 29372750
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
9. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
10. Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.
Nørgaard M; Nielsson MS; Heide-Jørgensen U
Subst Abuse; 2015; 9(Suppl 2):5-11. PubMed ID: 26512202
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.
Wiles JR; Isemann B; Mizuno T; Tabangin ME; Ward LP; Akinbi H; Vinks AA
J Pediatr; 2015 Dec; 167(6):1214-20.e3. PubMed ID: 26364984
[TBL] [Abstract][Full Text] [Related]
12. The effect of methadone dose regimen on neonatal abstinence syndrome.
McCarthy JJ; Leamon MH; Willits NH; Salo R
J Addict Med; 2015; 9(2):105-10. PubMed ID: 25599433
[TBL] [Abstract][Full Text] [Related]
13. Higher maternal doses of methadone does not increase neonatal abstinence syndrome.
Pizarro D; Habli M; Grier M; Bombrys A; Sibai B; Livingston J
J Subst Abuse Treat; 2011 Apr; 40(3):295-8. PubMed ID: 21255960
[TBL] [Abstract][Full Text] [Related]
14. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
15. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
16. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
17. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
19. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
[TBL] [Abstract][Full Text] [Related]
20. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
